Inovio Pharmaceuticals In...

1.52
-0.07 (-4.40%)
At close: Apr 04, 2025, 10:18 AM

Inovio Pharmaceuticals Statistics

Share Statistics

Inovio Pharmaceuticals has 36.67M shares outstanding. The number of shares has increased by 41.51% in one year.

Shares Outstanding 36.67M
Shares Change (YoY) 41.51%
Shares Change (QoQ) 1.57%
Owned by Institutions (%) 47.43%
Shares Floating 36.41M
Failed to Deliver (FTD) Shares 2.04K
FTD / Avg. Volume 0.24%

Short Selling Information

The latest short interest is 3.5M, so 9.71% of the outstanding shares have been sold short.

Short Interest 3.5M
Short % of Shares Out 9.71%
Short % of Float 9.79%
Short Ratio (days to cover) 11.22

Valuation Ratios

The PE ratio is -0.46 and the forward PE ratio is -0.71. Inovio Pharmaceuticals's PEG ratio is 0.01.

PE Ratio -0.46
Forward PE -0.71
PS Ratio 228.26
Forward PS 0.2
PB Ratio 0
P/FCF Ratio 0
PEG Ratio 0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Inovio Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.17.

Current Ratio 2.77
Quick Ratio 2.77
Debt / Equity 0.17
Debt / EBITDA -114.15
Debt / FCF -0.11
Interest Coverage -632.05

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $1.63K
Profits Per Employee $-800.4K
Employee Count 134
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -86.69% in the last 52 weeks. The beta is 0.92, so Inovio Pharmaceuticals's price volatility has been higher than the market average.

Beta 0.92
52-Week Price Change -86.69%
50-Day Moving Average 1.98
200-Day Moving Average 5.05
Relative Strength Index (RSI) 35.11
Average Volume (20 Days) 853.76K

Income Statement

In the last 12 months, Inovio Pharmaceuticals had revenue of 217.76K and earned -107.25M in profits. Earnings per share was -3.95.

Revenue 217.76K
Gross Profit 217.76K
Operating Income -112.4M
Net Income -107.25M
EBITDA -103.95M
EBIT -107.08M
Earnings Per Share (EPS) -3.95
Full Income Statement

Balance Sheet

The company has 65.81B in cash and 11.87B in debt, giving a net cash position of 53.95B.

Cash & Cash Equivalents 65.81B
Total Debt 11.87B
Net Cash 53.95B
Retained Earnings -1,730.2B
Total Assets 113.2M
Working Capital 62.5M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -104.08B and capital expenditures 0, giving a free cash flow of -104.08B.

Operating Cash Flow -104.08B
Capital Expenditures 0
Free Cash Flow -104.08B
FCF Per Share -3831.86
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -51616.91% and -49254.27%.

Gross Margin 100%
Operating Margin -51616.91%
Pretax Margin -49254269%
Profit Margin -49254.27%
EBITDA Margin -47735.19%
EBIT Margin -51616.91%
FCF Margin -47795033.43%

Dividends & Yields

INO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for INO is $16.5, which is 937.7% higher than the current price. The consensus rating is "Buy".

Price Target $16.5
Price Target Difference 937.7%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Stock Splits

The last stock split was on Jan 25, 2024. It was a backward split with a ratio of 1:12.

Last Split Date Jan 25, 2024
Split Type backward
Split Ratio 1:12

Scores

Altman Z-Score -23.05
Piotroski F-Score 1